Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling
Anticancer Research · 2025
DOI: 10.21873/anticanres.17445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Hasaya Dokduang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Fascioliasis.
Abstract (Originalsprache)
BACKGROUND/AIM: Cholangiocarcinoma (CCA) is an aggressive cancer with limited effective chemotherapy and targeted therapy options. Existing cell lines and animal models only partially mimic the characteristics of the tumor, highlighting the need for more effective models to study the biology of cancer and drug responses. This study aimed to establish and characterize patient-derived xenograft (PDX) models of CCA. MATERIALS AND METHODS: Tumor samples from 40 CCA patients were subcutaneously implanted into non-obese diabetic/ShiJic-severe combined immunodeficiency Jcl mice to establish patient-derived xenograft (PDX) models. Successfully engrafted tumors were passaged across three generations. Histological features were analyzed using H&E staining and immunohistochemistry for cytokeratin-19, cytokeratin-7, heppar-1 and arginase-1. Whole exome sequencing (WES) was performed to assess genetic stability and identify somatic mutations. RESULTS: A total of eight PDX models were successfully created, representing 20% of the total cases. Histological comparisons showed strong concordance between patient tumors and their corresponding xenografts in the eight PDX models across generations. WES analysis confirmed the genetic stability of the PDX models, with significant somatic mutations identified in key genes such as TTN, MUC12, ARID1A, TP53, and RNF43. CONCLUSION: The CCA PDX model could reflect both the histological and genetic characteristics of the original tumors, providing a valuable tool for studying tumor biology and serving as a preclinical model to develop personalized treatment options for CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.
- Faculty of Medicine, Mahasarakham University, Mahasarakham, Thailand.
- Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Department of Systems Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.
- Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Zitieren
APA
Dokduang, H., Jarernrat, A., Titapun, A., Sitthirak, S., Padthaisong, S., Kittirat, Y., Sangkamanon, S., Sa-Ngiamwibool, P., Wangwiwatsin, A., Klanrit, P., Namwat, N., Jusakul, A., Murakami, Y., & Loilome, W. (2025). Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. Anticancer Research. https://doi.org/10.21873/anticanres.17445
Vancouver
Dokduang H, Jarernrat A, Titapun A, Sitthirak S, Padthaisong S, Kittirat Y, et al. Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. Anticancer Research. 2025. doi:10.21873/anticanres.17445
BibTeX
@article{Dokduang2025,
author = {Dokduang, Hasaya and Jarernrat, Apiwat and Titapun, Attapol and Sitthirak, Sirinya and Padthaisong, Sureerat and Kittirat, Yingpinyapt and Sangkamanon, Sakkarn and Sa-Ngiamwibool, Prakasit and Wangwiwatsin, Arporn and Klanrit, Poramate and Namwat, Nisana and Jusakul, Apinya and Murakami, Yoshinori and Loilome, Watcharin},
title = {Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17445}
}
EUVIMED